Alvocidib Followed by Cytarabine Plus Daunorubicin in Newly Diagnosed Acute Myeloid Leukemia
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Clinical Cancer Research
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Phase I Study of Alvocidib Followed by 7+3 (Cytarabine + Daunorubicin) in Newly Diagnosed Acute Myeloid Leukemia
Clin. Cancer Res 2020 Sep 30;[EPub Ahead of Print], JF Zeidner, DJ Lee, M Frattini, GD Fine, J Costas, K Kolibaba, SP Anthony, D Bearss, BD SmithFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.